REDUCE-IT
Live / Registered — Registered (as of 04 Aug 2026)
What this means for you
Registered since 04 Aug 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 04 Aug 2032: the §8 declaration of use).
Record
- Serial number
- 99192534
- Registration number
- 8375462
- Mark type
- Word mark
- Filed
- 19 May 2025
- Published for opposition
- 16 Jun 2026
- Registered
- 04 Aug 2026
- Next maintenance filing
- §8 declaration of use, due by 04 Aug 2032 (grace period to 04 Feb 2033)
- Attorney of record
- Winfield B. Martin
Goods and services
- Class 042 — Scientific and technological services: Providing medical research information in the field of pharmaceuticals, namely, information regarding a medical study on cardiovascular risk reduction with icosapent ethyl
Owner
- Amarin Pharmaceuticals Ireland Limited, Dublin, IE
- Amarin Pharmaceuticals Ireland Limited, Dublin, IE
- Amarin Pharmaceuticals Ireland Limited, Dublin, IE
Prosecution history
- 04 Aug 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Aug 2026 — REGISTERED-PRINCIPAL REGISTER
- 16 Jun 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Jun 2026 — PUBLISHED FOR OPPOSITION
- 10 Jun 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 May 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 May 2026 — EXAMINER'S AMENDMENT ENTERED
- 14 May 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 14 May 2026 — EXAMINERS AMENDMENT E-MAILED
- 14 May 2026 — EXAMINERS AMENDMENT -WRITTEN
- 02 Apr 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Apr 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Apr 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 31 Dec 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 31 Dec 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED